A NEW BLEEDING DISORDER - LACK OF PLATELET AGGREGATORY RESPONSE TO ADRENALINE AND LACK OF SECONDARY AGGREGATION TO ADP AND PLATELET ACTIVATING FACTOR (PAF)

被引：1
作者：
STORMORKEN, H
GOGSTAD, G
SOLUM, NO
机构：
来源：
THROMBOSIS RESEARCH | 1983年 / 29卷 / 04期
关键词：
D O I：
10.1016/0049-3848(83)90242-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：391 / 402
页数：12
相关论文
共 50 条
  • [31] Molecular modeling on platelet-activating factor (PAF) and new proposed PAF antagonists
    DeSantAnna, CMR
    DeAlencastro, RB
    Fraga, CAM
    Barreiro, EJ
    Neto, JDD
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 1996, 60 (05) : 1069 - 1080
  • [32] Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy
    Tselepis, AD
    Goudevenos, JA
    Tambaki, AP
    Michalis, L
    Stroumbis, CS
    Tsoukatos, DC
    Elisaf, M
    Sideris, DA
    CARDIOVASCULAR RESEARCH, 1999, 43 (01) : 183 - 191
  • [33] INVIVO AGGREGATION OF GUINEA-PIG PLATELETS IN RESPONSE TO SYNTHETIC PLATELET ACTIVATING FACTOR (PAF-ACETHER)
    PAGE, CP
    PAUL, W
    MORLEY, J
    AGENTS AND ACTIONS, 1983, 13 (5-6): : 506 - 507
  • [34] PLATELET ACTIVATING FACTOR (PAF)-INDUCED AGGREGATION AND RELEASE RESPONSES INVITRO IN 3 SPECIES
    CARGILL, DI
    COHEN, DS
    VANVALEN, R
    LEE, ML
    SAUNDERS, RN
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 292 - 292
  • [35] Effects of a diacylglycerol kinase inhibitor, R59022, on platelet responses to ADP, thrombin and platelet-activating factor (PAF).
    Packham, MA
    Ruben, DH
    Rand, ML
    FASEB JOURNAL, 1996, 10 (06) : 2398 - 2398
  • [36] AN ANTAGONISTIC ACTIVITY OF ETIZOLAM (DEPAS) ON PLATELET-ACTIVATING-FACTOR (PAF) .1. EFFECTS ON PLATELET AND LEUKOCYTE AGGREGATION
    TAKEHARA, S
    MIKASHIMA, H
    TERASAWA, M
    MURAMOTO, Y
    YASUDA, H
    KURIHARA, A
    OKUMOTO, T
    TAHARA, T
    MARUYAMA, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P89 - P89
  • [37] VASOACTIVE INTESTINAL PEPTIDE (VIP) INHIBITS PLATELET-AGGREGATION AND SECRETION INDUCED BY PLATELET-ACTIVATING FACTOR (PAF)
    COX, CP
    SAID, SI
    FEDERATION PROCEEDINGS, 1983, 42 (04) : 1027 - 1027
  • [38] EFFECTS OF ANTIPLATELET AGENTS ON PLATELET-AGGREGATION INDUCED BY PLATELET - ACTIVATING FACTOR (PAF) IN HUMAN WHOLE-BLOOD
    CHAN, WP
    LEVY, JV
    PROSTAGLANDINS, 1991, 42 (04): : 337 - 342
  • [39] LACK OF INVOLVEMENT OF LEUKOTRIENE AND PLATELET ACTIVATING FACTOR IN PASSIVE CUTANEOUS ANAPHYLAXIS IN RATS
    TAIRA, M
    KOHNO, SW
    YAMAMURA, H
    OHATA, K
    AGENTS AND ACTIONS, 1988, 24 (1-2): : 189 - 195
  • [40] INDIVIDUAL VARIATION IN THE NASAL RESPONSE TO PLATELET-ACTIVATING-FACTOR (PAF) CHALLENGE
    DOLEN, W
    GARCIA, M
    WILLIAMS, B
    DANZIG, M
    LUTSKY, B
    CUSS, F
    SELNER, J
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 190 - 190
12345